ABSTRACT -Aim of the study: To report a case of unilateral headache with two possibilities of diagnosis. Method: Case re p o rt . Results: Patient with unilateral, intense, stabbing periocular headache with conjuntival injection and tearing. Although the duration of attacks was typical of SUNCT, there was complete remission of the pain with indomethacin, suggesting that this was a case of chronic paroxysmal hemicrania with unusually short attack duration. Conclusion: Therapeutic trials of indomethacin on younger patients presenting clinical diagnosis of SUNCT could be tried on a more regular basis.
The classification of headaches by the Intern a t i onal Headache Society (IHS) 1 classifies a special gro u p of headaches involving the trigeminal-autonomic system as belonging to "group 3 of primary headaches". These are typically re c u rrent, unilateral headaches of moderate to severe intensity, and relative short duration (from a few seconds to a few hours). They a re accompanied by conjuntival injection, tearing, rh i n o rrhea, sweating and pupillary alterations ipsilateral to the pain, denoting the involvement of the autonomic system. The most typical re p re s e n t a t i v e headache of this group is the cluster headache, described in 1952 2 . Other entities were described, including chronic paroxysmal hemicrania 3 and "Short -l a s ting Unilateral Neuralgiform headache attacks with Conjuntival injection and Tearing" (SUNCT) 4 but, as in cluster headache 5 , all these headaches can be in summary described as intense, accompanied mainly by lacrimation and conjuntival injection. The most typical diff e rence among these three headaches (and the neuralgia of the first division of the trigeminal n e rve as well 6) is the duration of the attacks 1 , although there are other features to be considere d , such as age of appearance of the headache, gender and trigger points 7 . The latter ones are not part of the diagnostic criteria. Table summarizes the main findings in these headaches from the group three of the international classification.
We re p o rt the case of a patient whose attacks of pain led to the discussion of the criteria "duration of the attack" as a setback for the classification of her headache.
CASE REPORT
Female caucasian patient, aged 48, presenting a history of headache for the last two years. The headache was strictly unilateral (left side) and, as described by the patient, it started all over the temporal area and within a couple of seconds it is "concentrated" on the left eye, which becomes red and "full of tears". The pain was very intense, like a "burning heavy pre s s u re stabbing on my eye" (9 out of 10 in the numeric pain intensity scale). The patient also re f e rred that, during the attack, a sensation of heat devel-oped in the left side of the forehead, followed by sweating. She described her appearance during the attack as following: "People who see me during an attack cannot believe how much I change in such a short time".
Since the beginning of this headache the attacks have always had these same characteristics, lasting one minute on average, and only once the pain lasted for nearly four minutes. The patient was very sure about the duration of the attacks and often timed it. The frequency of attacks was between 6 and 10 per day, and the patient did not know any way to force them to appear. She had been woken up by the attacks, though this was extremely rare to o c c u r. Previous to these two years, the patient had not experienced headaches. The present pain made the patient seek medical help with clinicians and, during the investigation, she received a variety of diagnosis she was not aware of. At the time of her consultation with us, she was underg oing treatment for high blood pressure, taking captopil 50 mg/day and hydro c h l o rthiazide 25 mg/day. She had diabetes mellitus type 2, well controlled with diet, metoform i n 850 mg/day and glibenclamide 15 mg/day. Hypert r i g l y c eridemia was under control with ciprofibrate 100 mg/day. All these medications had been in use for less than a year and did not have temporal relation to the headache. There was no family history of headaches. Her father had died t h ree years ago due to pneumonia, her mother was alive and well, with controlled diabetes mellitus type 2. Her clinical and neurological examinations were normal, except for exudates on the retina, classified as type I hypert e n s i v e retinopathy.
Although the headache was classified as SUNCT, we decided for a therapeutic trial with indomethacin considering it was worth excluding the diagnosis of chronic paro xysmal hemicrania. The patient re t u rned one m onth later with significant improvement of the headache taking indomethacin at the dose of 50 mg/day. The attacks were now infrequent, about one day per week, and the intensity of the pain was reduced to "m oderate, tolerable" (7 out of 10 in the visual analogical scale of pain). Indomethacin was suspended and the headache re t u rned with the same intensity and frequency after one day. Upon re s t a rting indomethacin, the headache was again much less frequent and less intense. The patient preferred to keep the dose of 50 mg/day rather than increasing it, claiming that the re m a i ning few attacks of headache were "perfectly tolerable". She remains with this dose and is very satisfied with the result.
The patient gave the informed consent for this case report.
DISCUSSION
SUNCT is one of the most rare and most difficult to treat types of headache. Despite descriptions of i m p rovement with the use of antiepileptic dru g s ( m o re recently known as membrane-stabilizing d ru g s ) , t h e re is no definite treatment for SUNCT 8 . On the other hand, chronic paroxysmal hemicrania is completely responsive to treatment with daily doses of i n d o m e t h a c i n 3 . SUNCT is more frequent in older mal e s 7 while chronic paroxysmal hemicrania pre d o m inates in younger females 9 . There have been cases of SUNCT described in younger women 1 0 and childre n 1 1 , but these are most infrequent.
The patient here described had a headache fulfilling all the criteria for diagnosis of SUNCT. However, being a female on her 4 t h decade, we considered it w o rth a trial with indomethacin, since SUNCT is a diagnosis that would invariably lead to a fru s t r a t i n g sequence of trial treatments. Indeed, if we had started her on other drugs than indomethacin, it is most likely that she would not have responded at all.
Having a successful remission of her headache with indomethacin, the case was then re -c l a s s i f i e d as "probable chronic paroxysmal hemicrania", since it did not fulfill item B of the classification of the IHS 1 , that it, the attacks did not last between two and 30 minutes. We considered this re-classification better than considering it to be a SUNCT case which full- , but responded to indomethacin.
The difficulties re g a rding classification of headaches in some patients led Young et al. to consider a modular theory for headaches 1 2 . These authors propose that groups of neurones called modules become activated to produce each symptom of a primary headache disord e r, and that each module is linked to other modules, producing the headache of a part i cular individual. A group of Brazilian authors has recently published a case with overlapping characteristics of episodic paroxysmal hemicrania and cluster headache 13 .
In the IHS criteria there is an overlap of duration of atacks bewteen SUNCT (five to 240 seconds) and c h ronic paroxysmal hemicrania (two to 30 minutes) making it difficult to classify attacks which last between 120 and 240 seconds. For some cases, it has been suggested that a trial of indomethacin could be perf o rmed in order to confirm or exclude the diagnosis of chronic paroxysmal hemicrania 1 4 . We suggest that such trial should be performed even if the attacks last for less than two minutes.
